Aarti Drugs erases 6.5% gain despite Q2 profit jump

Aarti Drugs shares hit an 11-month high on 4 Nov 2026 but closed 2.25% lower after Q2 profit rose 83.2%. Support is at 430 and resistance at 500. Aarti Drugs Limited [

] shares gained as much as 6.5% in morning trade on 4 November 2026 and touched an 11-month high. The gains faded before the close, and the stock ended the session 2.25% lower. The move followed Q2 consolidated results. Profit rose 83.2% year on year to Rs 82.9 crore, against Rs 45.3 crore. Revenue grew 26.6% to Rs 826.2 crore from Rs 652.8 crore. Profit grew faster than revenue, which points to stronger earnings growth in the quarter. A reversal from a high, on the day of strong results, shows buyers did not follow through. In my view, the fade from the high makes the setup cautious in the short term. Resistance sits at 500. A move above 500 would bring a continuation of the rally into focus. Support is at 430, and a fall below 430 would put a deeper pullback in view. Watch whether price holds above 430 in the next sessions and how it reacts near 500. Stance: cautious while price trades between 430 and 500. Disclaimer: I do not hold any position in this. This content is for informational purposes only and is not a recommendation to buy or sell. Investments in securities are subject to market risks. Please read all related documents carefully before investing.